| answer text |
<p>In order to improve the care and outcomes for people with progressive neurological
conditions, such as secondary progressive multiple sclerosis (MS), NHS England and
NHS Improvement produced a progressive neurological conditions RightCare toolkit,
in collaboration with key stakeholders such as the MS Trust and the MS Society. This
toolkit supports systems to understand the priorities in care for people living with
various progressive neurological conditions, in line with best practice guidelines.</p><p>
</p><p>The National Institute for Health and Care Excellence (NICE) guideline ‘Multiple
sclerosis in adults: management’, updated in 2019 sets out best practice on the diagnosis,
treatment, care and support of people MS. On secondary progressive MS, the guidance
sets out that “While a variety of symptomatic treatments is available, progression
in secondary progressive MS is currently intractable, and immunomodulatory strategies
used for relapse remitting MS have not proven effective when extended into secondary
progressive MS.”</p><p> </p><p> </p>
|
|
